Q2 2025 – Talk Bio

Uncertainty Clouds Finances for Payers and Health Systems in Q2 2025

2 months ago talkbio0Tagged Budgets, Changing, Consumer, federal, health systems, healthcare financial performance, Hospital admission, Medicaid, Medicare, payers, Policy, Q2 2025, Uncertainty

Q2 2025; healthcare financial performance; payers; health systems; uncertainty; Medicaid; Medicare; admissions; policy changes; federal budget; consumer confidence

Lilly’s Q2 2025 Beat-and-Raise Overshadowed by Orforglipron Data

2 months ago talkbio0Tagged earnings, Eli, Eli Lilly, Expectations, franchise, Glucagon-Like Peptide 1, Obesity, Oral cavity, orforglipron, Q2 2025, regulatory submission, Weight Loss

Eli Lilly; Q2 2025 earnings; orforglipron; oral GLP-1; weight loss; obesity franchise; regulatory submission; analyst expectations

AstraZeneca Beats Q2 Estimates on Strong Cancer Drug Sales

2 months ago talkbio0Tagged AstraZeneca, Cancer Drug Sales, Enhertu, financial results, Imfinzi, oncology portfolio, Q2 2025, Tagrisso

AstraZeneca; Q2 2025; cancer drug sales; oncology portfolio; Tagrisso; Imfinzi; Enhertu; financial results

Merck Announces $3 Billion Cost-Cutting and Restructuring Plan

2 months ago talkbio0Tagged Drug Industry, estate, Financial cost, Keytruda, Merck, Q2 2025, restructuring, Transection (procedure)

Merck; cost cutting; restructuring; job cuts; real estate reduction; Keytruda; pharmaceutical industry; Q2 2025 financials